Non-contrast transcatheter aortic valve implantation for patients with aortic stenosis and chronic kidney disease: a pilot study

被引:4
|
作者
Freire, Antonio Fernando Diniz [1 ]
Nicz, Pedro Felipe Gomes [1 ]
Ribeiro, Henrique Barbosa [1 ]
Filippini, Filippe Barcellos [1 ]
Accorsi, Tarso Duenas [1 ]
Liberato, Gabriela [1 ]
Nomura, Cesar Higa [1 ]
Cassar, Renata de Sa [1 ]
Vieira, Marcelo Luiz Campos [1 ]
Mathias Jr, Wilson [1 ]
Pomerantzeff, Pablo Maria Alberto [1 ]
Tarasoutchi, Flavio [1 ]
Abizaid, Alexandre [1 ]
Kalil Filho, Roberto [1 ]
de Brito Jr, Fabio Sandoli [1 ]
机构
[1] Univ Sao Paulo InCor, Dept Intervent Cardiol, Heart Inst, Sao Paulo, Brazil
来源
关键词
transcatheter aortic valve replacement; aortic stenosis; renal failure; zero contrast; renal insufficiency; OUTCOMES; INJURY; REPLACEMENT; PREDICTORS; IMPACT;
D O I
10.3389/fcvm.2023.1175600
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAcute kidney injury (AKI) is frequently observed after transcatheter aortic valve implantation (TAVI). Of note, it is associated with a threefold increase in all-cause and cardiac death. We propose a new non-contrast strategy for evaluating and performing the TAVI procedure that can be especially valuable for patients with aortic stenosis (AS) and chronic kidney disease (CKD) to prevent AKI. MethodsPatients with severe symptomatic AS and CKD stage & GE;3a were evaluated for TAVI using four non-contrast imaging modalities for procedural planning: transesophageal echocardiogram (TEE), cardiac magnetic resonance, multidetector computed tomography (MDCT), and aortoiliac CO2 angiography. Patients underwent transfemoral (TF) TAVI using the self-expandable Evolut R/Pro, and the procedures were guided by fluoroscopy and TEE. Contrast MDCT and contrast injection at certain checkpoints during the procedure were used in a blinded fashion to guarantee patient safety. ResultsA total of 25 patients underwent TF-TAVI with the zero-contrast technique. The mean age was 79.9 & PLUSMN; 6.1 years, 72% in NYHA class III/IV, with a mean STS-PROM of 3.0% & PLUSMN; 1.5%, and creatinine clearance of 49 & PLUSMN; 7 ml/min. The self-expandable Evolut R and Pro were implanted in 80% and 20% of patients, respectively. In 36% of the cases, the transcatheter heart valve (THV) chosen was one size larger than the one by contrast MDCT, but none of these cases presented adverse events. Device success and the combined safety endpoint (at 30 days) both achieved 92%. Pacemaker implantation was needed in 17%. ConclusionThis pilot study demonstrated that the zero-contrast technique for procedural planning and THV implantation was feasible and safe and might become the preferable strategy for a significant population of CKD patients undergoing TAVR. Future studies with a larger number of patients are still needed to confirm such interesting findings.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Transcatheter aortic valve implantation without contrast media technique in chronic kidney disease population - pilot study
    Nicz, P.
    Freire, A. F. D.
    Filippini, F. B.
    Kanhouche, G.
    Accorsi, T. A. D.
    Ribeiro, H. B.
    Liberato, G.
    Nomura, C. H.
    Cassar, R. S.
    Vieira, M. L.
    Mathias, W.
    Pomerantzeff, P. M. A.
    Tarasoutchi, F.
    Abizaid, A.
    De Brito, F. S., Jr.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2102 - 2102
  • [2] Noncontrast Transcatheter Aortic Valve Implantation for Patients With Aortic Stenosis and Chronic Kidney Disease: Long-Term Follow-Up of The Pilot Study
    Filippini, Filippe
    Freire, Antonio Fernando
    Nicz, Pedro
    Bratz, Guilherme
    Sessa, Bruno
    Ribeiro, Henrique
    Accorsi, Tarso
    Liberato, Gabriela
    Nomura, Cesar Higa
    Cassar, Renata
    Vieira, Marcelo
    Le Bihan, David
    Barretto, Rodrigo
    Mathias, Wilson
    Pomerantzeff, Pablo
    Tarasoutchi, Flavio
    Abizaid, Alexandre
    Brito, Fabio, Jr.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B182 - B182
  • [3] Chronic kidney disease and transcatheter aortic valve implantation
    Yuya Adachi
    Masanori Yamamoto
    Cardiovascular Intervention and Therapeutics, 2022, 37 : 458 - 464
  • [4] Chronic kidney disease and transcatheter aortic valve implantation
    Adachi, Yuya
    Yamamoto, Masanori
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (03) : 458 - 464
  • [5] Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease
    Conrotto, Federico
    Salizzoni, Stefano
    Andreis, Alessandro
    D'Ascenzo, Fabrizio
    D'Onofrio, Augusto
    Agrifoglio, Marco
    Chieffo, Alaide
    Colombo, Antonio
    Rapetto, Filippo
    Santini, Francesco
    Tarantini, Giuseppe
    Gabbieri, Davide
    Savini, Carlo
    Imme, Sebastiano
    Ribichini, Flavio
    Valsecchi, Orazio
    Aiello, Marco
    Lixi, Giovanni
    Iadanza, Alessandro
    Pompei, Esmeralda
    Stolcova, Miroslava
    Ornaghi, Diego
    Minati, Alessandro
    Cassese, Mauro
    Martinelli, Gian Luca
    Sbarra, Pierluigi
    Agostinelli, Andrea
    Audo, Andrea
    Pieroni, Andrea
    Fiorilli, Rosario
    Gerosa, Gino
    Rinaldi, Mauro
    Gaita, Fiorenzo
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (09): : 1438 - 1442
  • [6] Is transcatheter aortic valve implantation feasible in patients with chronic kidney disease?
    Doshi, Rajkumar
    Shah, Jay
    EUROINTERVENTION, 2019, 14 (17) : 1791 - 1791
  • [7] A Contrast Frugal Approach to Transcatheter Aortic Valve Replacement in Chronic Kidney Disease: A Pilot Study
    Bose, Subhasish
    Kanda, Brinder
    Roy, Sasmit
    Saum, Kenneth
    Haas, John
    El-Adhab, Fadi
    Ranson, Crystal
    Brunton, Nichole
    Morford, Reagan
    Tavaf-Motamen, Houman
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [8] Transcatheter Aortic Valve Implantation in Patients With Bicuspid Aortic Valve Stenosis
    Wijesinghe, Namal
    Ye, Jian
    Rodes-Cabau, Josep
    Cheung, Anson
    Velianou, James L.
    Natarajan, Madhu K.
    Dumont, Eric
    Nietlispach, Fabian
    Gurvitch, Ronen
    Wood, David A.
    Tay, Edgar
    Webb, John G.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (11) : 1122 - 1125
  • [9] Transcatheter valve implantation for patients with aortic stenosis
    Vahanian, Alec
    Himbert, Dominique
    Brochet, Eric
    HEART, 2010, 96 (22) : 1849 - 1856
  • [10] THE IMPACT OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH AORTIC STENOSIS
    Oancea, Andra
    Cobzeanu, Maria-Luiza
    Furnica, Cristina
    Chistol, Raluca Ozana
    Enache, M.
    Tarus, A.
    Corciova, Flavia
    Iliescu, Alina-Cristina
    Deju, Elena
    Tinica, Gr
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2021, 125 (03): : 420 - 428